Business
Rakovina Therapeutics Inc. Announces Inaugural Scientific Advisory Board
Rakovina Therapeutics Inc. Announces Inaugural Scientific Advisory Board Canada...
About this update from Rakovina Therapeutics Inc
[{"type":"text","content":"\n \n \n \n Rakovina Therapeutics Inc. Announces Inaugural Scientific Advisory Board\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n VANCOUVER, BC\n \n ,\n \n April 29, 2021\n \n /CNW/ -\n \n \n Today, Rakovina Therapeutics announced the formation of its inaugural Scientific Advisory Board. Made up of experts in biology, medicinal chemistry and pharmacology, the Scientific Advisory Board will contribute to Rakovina Therapeutics' development of new cancer treatments informed by the latest scientific research, and practical and clinical perspectives.\n \n \n \n \n \n \n \n \n \n \"We are thrilled to have such a talented and experienced scientific advisory board providing critical expertise to our team\", said\n \n Jeffrey Bacha\n \n , Rakovina Therapeutics executive chairman.  \"Rakovina Therapeutics will benefit from their invaluable input as we advance our pipeline of novel oncology assets.\"\n \n \n Rakovina Therapeutics is committed to advancing new cancer treatments based on novel DNA-damage response technologies.  Under the advisement of the Scientific Advisory Board, made up of world-class experts who have been directly involved in the successful development of multiple life-saving cancer treatments, Rakovina Therapeutics aims to develop innovative therapies for a range of cancer indications.\n \n \n \"Rakovina Therapeutics aims to become a leader in the development of new medicines in the fast-moving DNA-damage response field,\" said Prof.\n \n Mads Daugaard\n \n , Rakovina Therapeutics' president and chief scientific officer.  \"Working with our distinguished Scientific Advisory Board allows us to deepen our commitment to conducting leading edge scientific research and developing best-in-class cancer therapeutics, ultimately benefiting cancer patients and their families.\"\n \n \n \n \n The inaugural members of the Rakovina Therapeutics scientific advisory board include:\n \n \n \n \n \n \n Dennis Brown\n \n , PhD\n \n has been involved in cancer drug discovery and development for more than 35 years....